comscoreBiosimilars: What Are They and What Are Their Advantages?

Biosimilars: What Are They and What Are Their Advantages?

Dr. Philip Lammers explains what a biosimilar drug is and how we can be sure they are safe and effective.
Mar 30, 2017
00:00
Download
00:00

Dr. Philip Lammers has several active research projects on ways to increase minority and underserved population representation in clinical trials. He also studies state-of-the art cancer treatments, including biosimilars.

Listen to the podcast to hear Dr. Lammers explain:

  • what a biosimilar drug is, as well as the approval process for biosimilars

  • how we can be sure that biosimilars are as safe as the reference products

  • the advantages and disadvantages of biosimilars

  • when we might see biosimilars on the market to treat breast cancer

About the guest
 
Philip Lammers, MD, MSCI

Dr. Philip Lammers is a medical oncologist, the chief of the Division of Hematology/Oncology at Meharry Medical College, and adjunct assistant professor of internal medicine at Vanderbilt University.

— Last updated on June 29, 2022, 2:49 PM

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate